ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research
TOKYO, Japan — January 27, 2025 — ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch…